http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113201497-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N15-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113201497-B
titleOfInvention Method for inhibiting proliferation and migration ability of estrogen receptor positive breast cancer stem cells
abstract The invention discloses a method for inhibiting the proliferation and migration ability of estrogen receptor-positive breast cancer stem cells. The method adopts aminonucleoside antibiotics and peptidyltransferase inhibitor puromycin to treat estrogen receptor-positive breast cancer cells After MCF‑7 was labeled with an antibody, breast cancer stem cells were obtained by flow cytometry sorting, and treated with different doses of puromycin and at different times to achieve the purpose of inhibiting the proliferation and migration of estrogen receptor-positive breast cancer stem cells. Therefore, the method increases the application of the puromycin in the field of research and treatment of breast cancer, and simultaneously increases the application of the puromycin in the screening of anticancer drugs.
priorityDate 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453947315

Total number of triples: 32.